This article is more than 5 years old. Information may no longer be current.

VIDEO: Surgeon presents phase 3 clinical trial results of Rhopressa

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, L. Jay Katz, MD, FACS, discusses phase 3 clinical trial results of Aerie Pharmaceuticals' netarsudil ophthalmic solution 0.02%, also called Rhopressa, for lowering IOP in glaucoma patients.